Covered recipient · General Payments record
PAZRICA CHO
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,901.49
- Reported across 121 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $263.43 | 11 |
| Education | $27.27 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $146.40 | 5 |
| Acerta Pharma LLC | $82.62 | 4 |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 1 |
| ABBVIE INC. | $19.93 | 1 |
| Stryker Corporation | $14.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.93 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103463806 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.22 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105231681 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.51 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104534951 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.04 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105605009 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.85 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105509218 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 10/08/2024 | Education | Undisputed | 01/23/2026 | 1101362954 | CMS |
| Indivior Inc. | $16.64 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144525918 | CMS |
| Indivior Inc. | $41.31 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144525920 | CMS |
| Indivior Inc. | $24.13 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144525922 | CMS |
| Indivior Inc. | $24.09 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144525924 | CMS |
| Indivior Inc. | $40.23 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144525926 | CMS |
| Stryker Corporation | $14.48 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119798474 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.